Eton Pharmaceuticals, Inc. (ETON)

Eton Pharmaceuticals, Inc. (ETON) is a healthcare company (drug manufacturers - specialty & generic) based in the United States. The share price is $64.34, up 0.72% on the day, which values the company at $1.86B. Price as of 17 Nov 2026, 17:34 UTC, from Yahoo Finance.

Key facts

Share price
$64.34+0.72% today
Market value
$1.86B
P/E ratio
41.8×last 12 months
Forward P/E
19.5×
Funk Score
51/100
Against its own history
Well above its usual priceusual price $13.21
200-week average
$15.19324% above
Sector
Healthcare

Figures as of . Prices from Yahoo Finance (may be delayed); statements from company filings with the SEC and Yahoo Finance. Estimates, not advice.

Eton Pharmaceuticals, Inc. in more detail

ETON trades at 41.8× its last twelve months' earnings, 19.5× next year's expected earnings, 13.2× sales. Measured against its own history, the price is 387% above what its usual multiples would imply ($13.21) — well above its usual price. It sits 324% above its 200-week average of $15.19.

Over the last five fiscal years Eton Pharmaceuticals, Inc. has compounded revenue 359.6% a year. Its Funk Score is 51 out of 100 (financial strength 7.5, profitability 3.1, growth 9.3, value 0.3, each out of 10).

In its favour: Altman Z in the safe zone. Worth checking: Share count keeps rising; Gross margin is shrinking.

1 of the superinvestors tracked here hold ETON, including Polen Capital team (0.1% of the portfolio).

Superinvestors holding ETON

1 of the investors tracked here report a position in their latest 13F filing.

Eton Pharmaceuticals, Inc. (ETON): questions and answers

What is ETON's P/E ratio?

Eton Pharmaceuticals, Inc. trades at 41.8× its last twelve months' earnings and 19.5× next year's expected earnings.

What is Eton Pharmaceuticals, Inc.'s market cap?

Eton Pharmaceuticals, Inc. is valued at $1.86B at a share price of $64.34.

Is ETON overvalued or undervalued?

Against its own history, ETON is well above its usual price: the price is 387% above the $13.21 implied by the median multiples it has traded at (price / sales, price / book, price / free cash flow). That compares the stock with its past; it does not say whether the business now deserves a higher or lower multiple.

Is ETON above its 200-week moving average?

Yes. ETON is 323.6% above its 200-week average of $15.19. Long-term investors watch that line because strong companies rarely trade below it for long.

How fast is Eton Pharmaceuticals, Inc. growing?

Over the last five fiscal years Eton Pharmaceuticals, Inc.'s revenue grew 359.6% a year.

Does ETON pay a dividend?

Eton Pharmaceuticals, Inc. does not currently pay a regular dividend.

Cite this page

Funkfolio, “Eton Pharmaceuticals, Inc. (ETON) stock: price, valuation and fundamentals”, data as of 17 November 2026. https://funkfolio.com/stock/ETON

Underlying data: Yahoo Finance; company filings with the SEC.